Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance

Gary P H Ho1, Steven Margossian, Toshiyasu Taniguchi

  • 1Dana-Farber Cancer Institute, Department of Radiation Oncology, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

Insights

The Fanconi anemia (FA) pathway

Area of Science:

  • DNA damage response
  • Cell cycle regulation
  • Molecular biology

Background:

  • The Fanconi anemia (FA) pathway is crucial for DNA cross-linking resistance.
  • Monoubiquitination of FANCD2 is a key downstream event in the FA pathway.
  • ATM and ATR kinases play roles in FANCD2 modification and cell cycle checkpoints.

Purpose of the Study:

  • Identify novel DNA damage-inducible phosphorylation sites on FANCD2.
  • Investigate the role of ATR in FANCD2 monoubiquitination and cellular resistance.
  • Elucidate the involvement of ATM and ATR in FANCD2 phosphorylation and intra-S-phase checkpoint control.

Main Methods:

  • Site-directed mutagenesis to identify phosphorylation sites.
  • Western blotting to detect FANCD2 monoubiquitination.
  • siRNA-mediated knockdown of ATM and ATR kinases.
  • Analysis of intra-S-phase checkpoint activation.

Main Results:

  • Two novel DNA damage-inducible phosphorylation sites on FANCD2 identified: threonine 691 and serine 717.
  • ATR-mediated phosphorylation of Thr691 and Ser717 promotes FANCD2 monoubiquitination and resistance to cross-linking agents.
  • Phosphorylation of these sites is essential for the intra-S-phase checkpoint response.
  • ATM and ATR kinases collaborate in the IR-inducible phosphorylation of FANCD2.

Conclusions:

  • FANCD2 phosphorylation by ATR is critical for DNA damage resistance and cell cycle checkpoint control.
  • The FA pathway, through FANCD2, integrates DNA damage signaling with S-phase progression.
  • ATM and ATR kinases are key regulators of FANCD2 phosphorylation in response to DNA damage.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...